Inhibition of Pancreatic Cancer Cell Growth by Tyrosine Kinase Inhibitors
Author Information
Author(s): J. Gillespie, J.F. Dye, M. Schachter, P.J. Guillou
Primary Institution: St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine
Hypothesis
Can tyrphostins inhibit the growth of pancreatic cancer cells?
Conclusion
The tyrphostin AG17 effectively inhibits the growth of pancreatic cancer cells by targeting protein tyrosine kinases.
Supporting Evidence
- AG17 was found to be the most potent inhibitor of pancreatic cancer cell growth.
- Tyrphostins inhibited EGF and serum-stimulated DNA synthesis in pancreatic cancer cell lines.
- AG17 caused a dose-dependent and reversible inhibition of cell growth.
Takeaway
This study found that a special medicine called AG17 can stop pancreatic cancer cells from growing.
Methodology
The study used three human pancreatic cancer cell lines and measured DNA synthesis and cell growth after treatment with tyrphostins.
Limitations
The study primarily focused on in vitro results, and further in vivo studies are needed.
Participant Demographics
Three human pancreatic cancer cell lines were used: MiaPaCa-2, Panc-1, and CAV.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website